<prompt> Bosentan isEndothelin receptor blockerACEIIIbIIIa receptor blockerNone of the above  <response>: It is a dual endothelial receptor antagonist. FDA has approved the use of Bosentan for Raynauds phenomenan, pulmonary aery hypeension. Ref: HL Sharma 3rd ed,Vasoactive peptides 